The US Defense Threat Reduction Agency (DTRA) has awarded $35.7 million dollars to develop a recombinant vesicular stomatitis virus vector Marburg virus vaccine.
The European Commission announced it has granted a marketing authorization of Merck's Ebola vaccine Ervebo.
An experimental dengue vaccine has shown promising results in a large trial, but critical questions remain about effectiveness and safety. It is unknown whether the vaccine might increase disease severity in some recipients.
The US Government is funding a project to develop a vaccine for a pneumonia-like disease. The vaccine was effective in a one-month study with mice that found it prevented those treated from contracting melioidosis, a disease caused by contact with bacteria typically found in Puerto Rico, Southeast Asia, and Australia.
Researchers found structural similarities between the African swine fever virus and other diseases that could help develop effective drugs.
The Democratic Republic of the Congo will begin using a second Ebola vaccine as early as next week as part of a clinical trial.
The African swine fever virus is large and complex, about 20 times the size of other viruses which have effective vaccines, and traditional methods of vaccine development have been ineffective.
A gene editing enzyme could be used to disable RNA viruses such as influenza or Ebola.
Researchers have decoded how the body’s immune system reacts to a poorly understood Ebola virus vaccine, and how the body generates effective antibodies against the disease.
Researchers announced the first administration to study volunteers of a vaccine candidate against Lassa fever.virus.